Eclipse Continuity GP I, LLC - 10 Oct 2025 Form 4 Insider Report for Owlet, Inc. (OWLT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Oct 2025, 18:56:41 UTC
Prior SEC filing
22 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Eclipse Early Growth Fund I, L.P., by: Eclipse Early Growth GP I LLC, its General Partner, /s/ Lior Susan, Managing Member

Key filing fact

Eclipse Continuity GP I, LLC filed Form 4 for Owlet, Inc. (OWLT) on 15 Oct 2025.

Key facts

  • This page summarizes Eclipse Continuity GP I, LLC's Form 4 filing for Owlet, Inc. (OWLT).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 15 Oct 2025, 18:56.

Change

  • Previous filing in this sequence was filed on 22 Aug 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (6)

CIK 0001675124 Primary reporting owner

Eclipse Continuity GP I, LLC

Relationship
Director, Director by Deputization, 10%+ Owner
Address
514 HIGH STREET, SUITE 4, PALO ALTO
Signature
Eclipse Early Growth Fund I, L.P., by: Eclipse Early Growth GP I LLC, its General Partner, /s/ Lior Susan, Managing Member
Signature date
15 Oct 2025
CIK 0001877287

Eclipse Early Growth Fund I, L.P.

Relationship
Director, Director by Deputization, 10%+ Owner
Address
514 HIGH STREET, SUITE 4, PALO ALTO
Signature
Eclipse Early Growth GP I LLC, by /s/ Lior Susan, Managing Member
Signature date
15 Oct 2025
CIK 0001876955

Eclipse Early Growth GP I, LLC

Relationship
Director, Director by Deputization, 10%+ Owner
Address
514 HIGH STREET, SUITE 4, PALO ALTO
Signature
Eclipse Continuity GP I, LLC, /s/ Lior Susan, Managing Member
Signature date
15 Oct 2025
CIK 0001675126

Eclipse Continuity Fund I, L.P.

Relationship
Director, Director by Deputization, 10%+ Owner
Address
514 HIGH STREET, SUITE 4, PALO ALTO
Signature
Eclipse Continuity Fund I, L.P., By: Eclipse Continuity GP I, LLC, its General Partner, /s/ Lior Susan, Managing Member
Signature date
15 Oct 2025
CIK 0001843678

Eclipse Ventures GP I, LLC

Relationship
Director, Director by Deputization, 10%+ Owner
Address
514 HIGH STREET, SUITE 4, PALO ALTO
Signature
Eclipse Ventures GP I, LLC, /s/ Lior Susan, Managing Member
Signature date
15 Oct 2025
CIK 0001641394

Eclipse Ventures Fund I, L.P.

Relationship
Director, Director by Deputization, 10%+ Owner
Address
514 HIGH STREET, SUITE 4, PALO ALTO
Signature
Eclipse Ventures Fund I, L.P., By: Eclipse Ventures GP I, LLC, its General Partner, /s/ Lior Susan, Managing Member
Signature date
15 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OWLT transaction

Common Stock

Award

Transaction value
Shares
+3,898,906
Change %
+221%
Price
Shares after
5,665,669
Date
10 Oct 2025
Ownership
See footnote
Footnotes
F1, F2
OWLT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
968,694
Date
10 Oct 2025
Ownership
See footnote
Footnotes
F3
OWLT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,066,472
Date
10 Oct 2025
Ownership
See footnote
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OWLT transaction Derivative

Series A Warrants (Right to Purchase Shares of Common Stock)

Disposed to Issuer

Transaction value
Shares
-5,300,291
Change %
-100%
Price
Shares after
0
Date
10 Oct 2025
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
5,300,291
Exercise price
Footnotes
F1, F2
OWLT transaction Derivative

Series B Warrants (Right to Purchase Shares of Common Stock)

Disposed to Issuer

Transaction value
Shares
-1,166,935
Change %
-100%
Price
Shares after
0
Date
10 Oct 2025
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
1,166,935
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

Footnote F2

The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Footnote F3

The securities are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Lior Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.

Footnote F4

The securities are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I", and collectively with Eclipse EGF I and Eclipse I, the "Eclipse Funds"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any.

SEC remarks

Lior Susan, the sole Managing Member of each of Eclipse EG GP I, Eclipse I GP and Eclipse Continuity GP, was elected to the board of directors of the Issuer as a representative of the Eclipse Funds. As a result, each of Eclipse EG GP I, Eclipse I GP and Eclipse Continuity GP and the Eclipse Funds is a director by deputization of the Issuer solely for purposes of Section 16 of the Act. Mr. Susan, due to his status as a director of the Issuer, files separate Section 16 reports.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .